Clinical study on the use of Escherichia coli–derived recombinant human BMP-2 combined with β-tricalcium phosphate for the treatment of long-bone nonunion: A phase I/II trial
Clinical study on the use of Escherichia coli–derived recombinant human BMP-2 combined with β-tricalcium phosphate for the treatment of long-bone nonunion: A phase I/II trial. // Journal of Orthopaedic Science. – URL: https://www.sciencedirect.com/science/article/pii/S0949265826002927?dgcid=rss_sd_all
Clinical study on the use of Escherichia coli–derived recombinant human BMP-2 combined with β-tricalcium phosphate for the treatment of long-bone nonunion: A phase I/II trial. Journal of Orthopaedic Science. https://www.sciencedirect.com/science/article/pii/S0949265826002927?dgcid=rss_sd_all
“Clinical study on the use of Escherichia coli–derived recombinant human BMP-2 combined with β-tricalcium phosphate for the treatment of long-bone nonunion: A phase I/II trial.” Journal of Orthopaedic Science.
@article{article54914,
title = {Clinical study on the use of Escherichia coli–derived recombinant human BMP-2 combined with β-tricalcium phosphate for the treatment of long-bone nonunion: A phase I/II trial},
journal = {Journal of Orthopaedic Science},
url = {https://www.sciencedirect.com/science/article/pii/S0949265826002927?dgcid=rss_sd_all}
}